Effects of Tumor Necrosis Factor‐α Inhibitors Pentoxifylline and Thalidomide on Alveolar Bone Loss in Short‐Term Experimental Periodontal Disease in Rats
- 1 January 2004
- journal article
- Published by Wiley in The Journal of Periodontology
- Vol. 75 (1), 162-168
- https://doi.org/10.1902/jop.2004.75.1.162
Abstract
The data showed a protective effect of PTX and TLD on experimental periodontitis, suggesting a role for TNF-α in the pathophysiology of periodontitis. J Periodontol 2004;75:162-168.Keywords
This publication has 24 references indexed in Scilit:
- Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifyllineInternational Journal of Immunopharmacology, 1996
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Effect of infection with Eikenella corrodens on the progression of ligature‐induced periodontitis in ratsJournal of Periodontal Research, 1990
- Periodontal DiseaseNew England Journal of Medicine, 1990
- Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortalityLife Sciences, 1989
- PentoxifyllineDrugs, 1987
- The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment lossJournal of Periodontal Research, 1986
- Alveolar bone destruction in the immunosuppressed ratJournal of Periodontal Research, 1982
- The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with Periodontopathic microorganismsJournal of Periodontal Research, 1978